Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 10.09
+0.02 (0.20%)
Jan 23, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 6.67 billion as of January 23, 2026. Its market cap has decreased by -12.26% in one year.
Market Cap
6.67B
Enterprise Value
9.17B
Revenue
1.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.09
Market Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has increased from 4.81B to 6.67B, an increase of 38.74%. That is a compound annual growth rate of 2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 6.67B | 10.88% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Aidea Pharmaceutical Group | 7.65B |
| Suzhou Fengbei Biotech Stock | 7.16B |
| Beijing Konruns Pharmaceutical | 6.77B |
| Kexing Biopharm | 6.66B |
| Jiangsu Bioperfectus Technologies | 6.66B |
| R&G PharmaStudies | 6.66B |
| Shanghai OPM Biosciences | 6.48B |
| PharmaResources (Shanghai) | 6.37B |